Citation Impact
1 by Nobel laureates 62 standout
Citing Papers
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
TET2-mediated tumor cGAS triggers endothelial STING activation to regulate vasculature remodeling and anti-tumor immunity in liver cancer
2024 Standout
Works of T.-Y. Kim being referenced
IMbrave150: Efficacy and safety results from a ph III study evaluating atezolizumab (atezo) + bevacizumab (bev) vs sorafenib (Sor) as first treatment (tx) for patients (pts) with unresectable hepatocellular carcinoma (HCC)
2019
Author Peers
| Author | Oncology | PRM | Hepatology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|
| T.-Y. Kim | 203 | 120 | 120 | 19 | 391 | |
| J.F. Caddy | 56 | 3.0k | ||||
| A Hugelin | 3 | 193 | 61 | 1.2k | ||
| R.T. Naudé | 1 | 39 | 637 | |||
| Daniël Brand | 35 | 1.1k | ||||
| Patricia Morcillo | 15 | 8 | 27 | 841 |
All Works
Loading papers...